Covestor’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9K Buy
500
+17
+4% +$238 0.01% 1665
2026
Q1
$5K Sell
483
-418
-46% -$4.59K ﹤0.01% 1804
2025
Q4
$11K Buy
901
+22
+3% +$292 0.01% 1524
2025
Q3
$13K Buy
879
+528
+150% +$7.23K 0.01% 1464
2025
Q2
$4K Sell
351
-4,029
-92% -$58.5K ﹤0.01% 1772
2025
Q1
$96K Sell
4,380
-1,043
-19% -$24.5K 0.06% 518
2024
Q4
$123K Buy
5,423
+2,071
+62% +$45.2K 0.08% 396
2024
Q3
$61K Sell
3,352
-253
-7% -$5.86K 0.04% 796
2024
Q2
$106K Buy
3,605
+1,559
+76% +$46.2K 0.07% 446
2024
Q1
$73K Sell
2,046
-28
-1% -$1.12K 0.05% 720
2023
Q4
$90K Buy
2,074
+37
+2% +$1.46K 0.06% 567
2023
Q3
$78K Buy
2,037
+921
+83% +$38.7K 0.06% 564
2023
Q2
$46K Buy
1,116
+191
+21% +$9.19K 0.04% 816
2023
Q1
$53K Sell
925
-458
-33% -$25.8K 0.05% 688
2022
Q4
$78K Buy
1,383
+434
+46% +$22.1K 0.06% 526
2022
Q3
$40K Buy
949
+407
+75% +$20.9K 0.04% 782
2022
Q2
$29K Sell
542
-1,016
-65% -$61K 0.02% 899
2022
Q1
$100K Buy
1,558
+602
+63% +$39.6K 0.07% 502
2021
Q4
$64K Buy
+956
New +$64.7K 0.09% 388

Other funds holding IART

Covestor's IART Position: Q2 2026 in Review

Covestor increased its Integra LifeSciences (IART) stake by 3.5% in Q2 2026, buying an estimated $238 and bringing the position to 500 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #1665.

Covestor first reported a position in IART in Q4 2021 and has held it in 19 quarters since. The position peaked at $123K in Q4 2024. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Covestor held 500 shares of Integra LifeSciences worth $9K as of Q2 2026.
  • Covestor bought 17 Integra LifeSciences shares in Q2 2026, an estimated $238.
  • Integra LifeSciences made up 0.01% of Covestor's portfolio in Q2 2026, its #1665 holding.
  • Covestor first reported a position in Integra LifeSciences in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Integra LifeSciences position peaked at $123K in Q4 2024.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.